Selected cutaneous adverse events in patients treated with ICI monotherapy and combination therapy: a retrospective pharmacovigilance study and meta-analysis von Lu, Wenchao, Zhang, Huiyun, Guo, Qixiang, Gou, Zhuoyue, Yao, Jiannan

Volltext

Pericardial Toxicities Associated With Immune Checkpoint Inhibitors: A Pharmacovigilance Analysis of the FDA Adverse Event Reporting System (FAERS) Database von Ma, Zhuo, Pei, Jie, Sun, Ximu, Liu, Lihong, Lu, Wenchao, Guo, Qixiang, Lyu, Jiayou, Liu, Yuwei, Zhang, Yuhui, Zhao, Zhixia

Volltext

Ibrutinib-related skin cancer: A pharmacovigilance study from the Food and Drug Administration Adverse Event Reporting System von Sun, Ximu, Ma, Zhuo, Guo, Qixiang, Zhao, Zhixia, Liu, Lihong

Volltext

Cholecystitis and cholangitis associated with lenvatinib: A pharmacovigilance study von Lu, Wenchao, Tang, Borui, Guo, Qixiang, Zhao, Zhixia, Liu, Lihong

Volltext

Asymmetric [3+2] Cycloaddition Reactions of α‐Substituted Diazophosphonates with 3‐Acryloyl‐2‐oxazolidinone to Access Chiral Pyrazoline Derivatives with Phosphonyl at a Tetrasubsti... von Huang, Nan, Tong, Xunfei, Zhou, Surong, Guo, Qixiang, Peng, Yungui

Volltext

Anti-angiogenic agent-associated adrenal insufficiency in immune checkpoint inhibitors-treated patients von Guo, Qixiang, Lu, Wenchao, Sun, Ximu, Zhao, Zhixia, Liu, Lihong

Volltext

Lenvatinib and osteonecrosis of the jaw: A pharmacovigilance study von Lu, Wenchao, Guo, Qixiang, Ma, Zhuo, Liu, Lihong, Zhao, Zhixia

Volltext

Direct α-Alkylation of Aldehydes by Brønsted-Acid Catalysis von Zhu, Xiangrong, Wang, Ting, Guo, Qixiang

Volltext

Catalytic Asymmetric Three-Component Reaction of 2‑Alkynylbenzaldehydes, Amines, and Dimethylphosphonate von Zou, Liangliang, Huang, Jiaying, Liao, Na, Liu, Yan, Guo, Qixiang, Peng, Yungui

Volltext

Evaluation of clinical trial designs for novel anticancer drugs in China: A cohort study of drugs approved between 2015 and 2021 von Luo, Xingxian, Guo, Qixiang, Du, Xin, Huang, Lin, Chow, Shein-Chung, Yang, Yue

Volltext

Risk of pneumonitis in cancer patients treated with PARP inhibitors: A meta-analysis of randomized controlled trials and a pharmacovigilance study of the FAERS database von Ma, Zhuo, Sun, Ximu, Zhao, Zhixia, Lu, Wenchao, Guo, Qixiang, Wang, Shihao, You, Jiwen, Zhang, Yuhui, Liu, Lihong

Volltext

Molecular engineering of highly efficient dopant-free spiro-type hole transporting materials for perovskite solar cells von Zhang, Yan, Wu, Fei, Chen, Lei, Zhang, Fengying, Ji, Yu, Shen, Wei, Li, Ming, Guo, Qixiang, Su, Wei, He, Rongxing

Volltext

Assessment of Efficacy Evidence for Approvals of Novel Drugs in China Between 2018 and 2022 von Xu, Yang, Li, Xinyu, Guo, Qixiang, Chen, Qi, Su, Mengfan, Zhang, Xuenong, Yang, Yue

Volltext

Assessment of clinical benefit, cost and uptake of biosimilars versus reference biologics in immune-mediated inflammatory diseases in China von Xin Du, Xingxian Luo, Qixiang Guo, Qixiang Guo, Xiaomeng Jiang, Xiaomeng Jiang, Ziling Su, Weiting Zhou, Zhongjian Wang, Jiarun Li, Yue Yang, Yue Yang, Yi Zhang

Volltext

Clinical Benefit, Price, and Uptake for Cancer Biosimilars vs Reference Drugs in China: A Systematic Review and Meta-Analysis von Luo, Xingxian, Du, Xin, Li, Zhuangqi, Liu, Jingwen, Lv, Xufeng, Li, Haoran, Guo, Qixiang, Wang, Cen, Xue, Xuecai, Le, Kaidi, Jiang, Xiaomeng, Huang, Lin, Yang, Yue

Volltext

The price, efficacy, and safety of within-class targeted anticancer medicines between domestic and imported drugs in China: a comparative analysis von Luo, Xingxian, Du, Xin, Huang, Lin, Guo, Qixiang, Tan, Ruijie, Zhou, Yue, Li, Zhuangqi, Xue, Xuecai, Li, Taifeng, Le, Kaidi, Qian, Feng, Chow, Shein-Chung, Yang, Yue

Volltext

Evidence of pre-approval clinical trial supporting the granted conditional approval for novel cancer drugs in China between 2015 and 2022Research in context von Xingxian Luo, Xin Du, Lin Huang, Qixiang Guo, Xufeng Lv, Cen Wang, Haopeng Liu, Yue Zhou, Xuecai Xue, Zhuangqi Li, Jingwen Liu, Shein-Chung Chow, Yue Yang

Volltext

Evidence of pre-approval clinical trial supporting the granted conditional approval for novel cancer drugs in China between 2015 and 2022 von Luo, Xingxian, Du, Xin, Huang, Lin, Guo, Qixiang, Lv, Xufeng, Wang, Cen, Liu, Haopeng, Zhou, Yue, Xue, Xuecai, Li, Zhuangqi, Liu, Jingwen, Chow, Shein-Chung, Yang, Yue

Volltext

The price, efficacy, and safety of within-class targeted anticancer medicines between domestic and imported drugs in China: a comparative analysisResearch in context von Xingxian Luo, Xin Du, Lin Huang, Qixiang Guo, Ruijie Tan, Yue Zhou, Zhuangqi Li, Xuecai Xue, Taifeng Li, Kaidi Le, Feng Qian, Shein-Chung Chow, Yue Yang

Volltext

Effects of Deposition Pressure on the Microstructure,Mechanical Behavior and High-Temperature Oxidation Resistance of AlCrTiSiN Coatings von GUAN Mengxue, FAN Qixiang, GUO Minglu, ZHANG Shuo, HAO Xuehui, WU Zhenghuan, CAO Fengting, WANG Tiegang

Volltext